Updated NPWT Hero Image.png

Achieving clinical outcomes while tackling costs and inefficiencies

NPWT has well-documented clinical benefits across acute and chronic wound indications,3-5 yet there may be obstacles to clinician confidence and timely therapy initiation.1,2

  • NPWT decision-making can be complex, which may impact clinician confidence and wound outcomes2,6
  • 38% of patients discontinue their therapy sooner than clinically recommended, many of whom due to the impact on their quality of life7
  • Logistics and paperwork relating to tNPWT can create additional work, potentially delaying patient discharge and increasing overall costs of care2,8
  • Costs are increasing quicker than budgets, and complex inventory management can be a drain on resources
HERO-2-IMAGES-840x840-NPWT.png

Con il consenso degli esperti di tutto il mondo

Gli esperti raccomandano di introdurre un approccio basato sulle evidenze per semplificare e ottimizzare l’utilizzo della NPWT, nonché per orientarsi nella scelta dei sistemi NPWT appropriati.

La capacità di scegliere rapidamente un sistema NPWT monouso, come ad esempio il PICO sNPWT, per le ferite idonee sotto il profilo clinico, può contribuire a:

Reduce the number of NPWT options and simplify your inventory to help optimise the clinical benefits of NPWT using our proprietary traditional and single-use technologies. Clinical studies have demonstrated:

  • Improved patient comfort and tolerability with the RENASYS System’s unique Soft Port Technology*9
  • The RENASYS TOUCH System was found to be comfortable by over 90% of patients4
  • The PICO System helps to promote healing progression and shorten time to healing**5,10
  • PICO sNPWT was shown to improve the area, depth and volume of lower extremity ulcer wounds***11
  • 97.5% of patients report being satisfied or pleased with PICO sNPWT treatment****12

Contact us

Disclaimer

*n=96; rispetto ad altri port.

**Progressione della guarigione rispetto alla traiettoria basale e guarigione rispetto alle previsioni per le cure standard; n= 52 ferite. In termini di risposta delle ferite croniche in stasi con una durata media di 44 settimane, il sistema PICO ha determinato la guarigione del 56% delle ferite con un anticipo medio di 10 settimane rispetto a quanto previsto con le medicazioni standard per la cura delle ferite; n= 9.

***Rispetto alla NPWT tradizionale nell’arco di un periodo di trattamento di 12 settimane per le VLU e le DFU, n= 161; analisi ITT.

****n=326.

Citations
  1. Hurd T. et al. Wounds 2021;33 (suppl 2):S1– S11.
  2. Kirsner R, et al. Wounds 2020;32(12).
  3. Saunders C, et al. BJS Open. 2021;0(0):1 - 8.
  4. Forlee M, et al. Poster presented at: EWMA;9-11 May, 2018; Krakow, Poland.
  5. Dowsett C, et al. Wounds International. 2017;8(2):52-58.
  6. Cray A. . Br J Nurs. 2017 Aug 10;26(15):S6-S18.
  7. Janssen AHJ, et al. J Tissue Viability. 2021 Feb 6.
  8. Kantar Health market research report, November 2018.
  9. Carnali M, et al. Acta Vulnologica. Vol 142016:24-39.
  10. Hampton J. Community Wound Care. 2015:S14-S20.
  11. Kirsner R, et al. Wound Repair Regen. 2019;27(5):519 - 529.
  12. Hurd T, et al. Ostomy Wound Manage. 2014;60(3):30-36.

Title

Text